AWM
PTCT icon

Avior Wealth Management’s PTC Therapeutics PTCT Stock Holding History

Avior Wealth Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+3,780
New +$273K 0.01% 655
2024
Q2 		– Sell
-14
Closed -$407 – 3362
2024
Q1 		$407 Buy
+14
New +$392 ﹤0.01% 2620

Other funds holding PTCT

New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Avior Wealth Management's PTCT Position: Q2 2026 in Review

Avior Wealth Management opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 3,780 shares worth $308K. The stake represents 0.01% of the portfolio and ranks #655 among its holdings. This is a return to the name: Avior Wealth Management previously reported a position in PTCT as recently as Q1 2024.

Avior Wealth Management first reported a position in PTCT in Q1 2024 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Avior Wealth Management held 3,780 shares of PTC Therapeutics worth $308K as of Q2 2026.
  • PTC Therapeutics was a new Avior Wealth Management position in Q2 2026.
  • PTC Therapeutics made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #655 holding.
  • Avior Wealth Management first reported a position in PTC Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.